[go: up one dir, main page]

MD596Z - Method for treating chronic viral hepatitis C in children - Google Patents

Method for treating chronic viral hepatitis C in children

Info

Publication number
MD596Z
MD596Z MDS20120138A MDS20120138A MD596Z MD 596 Z MD596 Z MD 596Z MD S20120138 A MDS20120138 A MD S20120138A MD S20120138 A MDS20120138 A MD S20120138A MD 596 Z MD596 Z MD 596Z
Authority
MD
Moldova
Prior art keywords
glucopyranosyl
viral hepatitis
chronic viral
children
day
Prior art date
Application number
MDS20120138A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Константин СПЫНУ
Татьяна РАБА
Игорь СПЫНУ
Владимир ГУРЬЕВ
Октавиан САЖЕН
Original Assignee
Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова filed Critical Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова
Priority to MDS20120138A priority Critical patent/MD596Z/en
Publication of MD596Y publication Critical patent/MD596Y/en
Publication of MD596Z publication Critical patent/MD596Z/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicine, in particular to hepatology, and can be used for the treatment of chronic viral hepatitis C.According to the invention, the claimed method consists in that it is administered the basic therapy and additionally, is concomitantly administered per os 5α-furostan-3β,22,26-triol-3-[O-β-D-glucopyranosyl(1→2)-β-D-glucopyranosyl (1→4)-β-D-galactopyranosyl]-26-O-β-D-glucopyranosyl, twice a day, and 3-O-[β-D-glucopyranosyl(1→2)]-[β-D-glucopyranosyl(1→3)]-[β-D-glucopyranosyl(1→4)-β-D-galactopyranosyl[(25R)-5α-furostan-2α, 3β, 22α, 26-tetraol]-26-O-β-D-glucopyranosyl, once a day, both remedies are administered in a dose of 50 mg, beginning with the first day of clinical manifestations, 30 minutes before meal, during 3 months.
MDS20120138A 2012-10-09 2012-10-09 Method for treating chronic viral hepatitis C in children MD596Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20120138A MD596Z (en) 2012-10-09 2012-10-09 Method for treating chronic viral hepatitis C in children

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20120138A MD596Z (en) 2012-10-09 2012-10-09 Method for treating chronic viral hepatitis C in children

Publications (2)

Publication Number Publication Date
MD596Y MD596Y (en) 2013-02-28
MD596Z true MD596Z (en) 2013-09-30

Family

ID=47831233

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20120138A MD596Z (en) 2012-10-09 2012-10-09 Method for treating chronic viral hepatitis C in children

Country Status (1)

Country Link
MD (1) MD596Z (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD667Z (en) * 2013-03-20 2014-03-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for treatment of infectious mononucleosis in children

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2046139C1 (en) * 1993-02-02 1995-10-20 Институт генетики АН Республики Молдова Inhibitor of rotaviruses
US5846964A (en) * 1993-07-19 1998-12-08 Tokyo Tanabe Company Limited Hepatitis C virus proliferation inhibitor
MD1875G2 (en) * 1999-11-01 2002-09-30 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treatment of the acute viral hepatitis B
MD2203G2 (en) * 2001-04-11 2004-01-31 Институт Генетики И Физиологии Растений Академии Наук Молдовы Process for treatment of pepper seeds
MD2549G2 (en) * 2003-07-18 2005-08-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treatment of the chronic viral hepatitis C
MD3121G2 (en) * 2005-09-15 2007-03-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of viral hepatitis B prophylaxis
MD3477G2 (en) * 2007-03-21 2008-08-31 Николае БОДРУГ Method of treating the chronic viral hepatitis C
MD177Z (en) * 2010-01-15 2010-11-30 Институт Генетики, Физиологии И Защиты Растений Академии Наук Молдовы Process for the treatment of apricot
US20120277266A1 (en) * 2009-03-30 2012-11-01 Bristol-Myers Squibb Company Hepatitis C Virus Inhibitors
  • 2012

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2046139C1 (en) * 1993-02-02 1995-10-20 Институт генетики АН Республики Молдова Inhibitor of rotaviruses
US5846964A (en) * 1993-07-19 1998-12-08 Tokyo Tanabe Company Limited Hepatitis C virus proliferation inhibitor
MD1875G2 (en) * 1999-11-01 2002-09-30 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treatment of the acute viral hepatitis B
MD2203G2 (en) * 2001-04-11 2004-01-31 Институт Генетики И Физиологии Растений Академии Наук Молдовы Process for treatment of pepper seeds
MD2549G2 (en) * 2003-07-18 2005-08-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treatment of the chronic viral hepatitis C
MD3121G2 (en) * 2005-09-15 2007-03-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of viral hepatitis B prophylaxis
MD3477G2 (en) * 2007-03-21 2008-08-31 Николае БОДРУГ Method of treating the chronic viral hepatitis C
US20120277266A1 (en) * 2009-03-30 2012-11-01 Bristol-Myers Squibb Company Hepatitis C Virus Inhibitors
MD177Z (en) * 2010-01-15 2010-11-30 Институт Генетики, Физиологии И Защиты Растений Академии Наук Молдовы Process for the treatment of apricot

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
A.Olinescu, L. Andrieş ,,Tehnici imunologice " Ştiinţa, 1994, Chişinău, p.260-268. *
American Gastroenterological Association ,, Medical Position Stateman on the Management of Hepatitis C for children, " 2006 *
Dumbrava Vlada-Tatiana. Hepatologie bazată pe dovezi.Ghid practic naţional pentru medici de familie, internişti şi gastroenterologi, Chişinău, 2005, p. 117-120. *
Grigorescu M., Pascu O. Tratat de gastroenterologie. Clinică. Editura tehnică, Bucureşti, vol. 2, 1997, p. 368-372. *
Guidelines for children, American Association for Study of Liver Deseases (AASLD), 2004 *
Guidelines However, American Association for the Study of Liver Diseases (AASLD), 2007. *
Бурении Н. Л., Котова Г. Н. Справочник по пчеловодству. Москва: Колос, 1977, с. 366 *
Ершов Ф. И. и др. Новый индуктор интерферона, активный при пероральном введении. Вопросы вирусологии, 1986, № 3, т. 31, с. 335-338 *

Also Published As

Publication number Publication date
MD596Y (en) 2013-02-28

Similar Documents

Publication Publication Date Title
PH12016500619A1 (en) Dry powder inhaler
MX2014001050A (en) Treatment of multiple sclerosis with combination of laquinimod and glatiramer acetate.
WO2007081773A3 (en) Treatment of fatty liver
EA201650134A1 (en) SPECIFIC COMBINED THERAPY OF MALIGNANT TUMORS BY CYTOSTATIC AND ITS MODIFIER
BR112015000136A2 (en) dietary fiber for use in treating a gastrointestinal side effect of a nutrition or medicine
MX2011009757A (en) Method of treating nonalcoholic steatohepatitis with elevated doses of ursodeoxycholic acid.
RU2017134443A (en) METHOD OF TREATMENT WITH USE OF TRADIPTANT
WO2012063134A3 (en) Cardiac glycoside analogs in combination with emodin for cancer therapy
BR112012027092A2 (en) methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
HRP20192189T1 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
MX2021006751A (en) Dry powder inhaler comprising fluticasone propionate and salmeterol xinafoat.
WO2010042701A3 (en) Corticosteroid compositions for use in treating diseases of the upper and lower airway passages
MX2023007826A (en) Methods comprising fixed intermittent dosing of cediranib.
MD596Z (en) Method for treating chronic viral hepatitis C in children
MD20060037A (en) Method of treating the acute viral hepatitis C
BR112012011316A2 (en) tivozanib and temsirolimus in combination
MD4177C1 (en) Method for vaccination against hepatitis B of persons with immunodeficiency
MD967Y (en) Method for treating chronic viral hepatitis B with cholestatic syndrome in children
Eeftinck Schattenkerk Antiallergics/ritonavir interaction
Bersanelli Asthenia: case report
CN106466348A (en) A kind of prescription treating hyperlipidemia
MD3987C2 (en) Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency
Iastrebov Treatment-resistant depressions in borderline psychiatry
MD520Z (en) Method for postoperative treatment of patients with nephrolithiasis
Lin Hypertension, diarrhoea and hand-foot syndrome: 4 case reports

Legal Events

Date Code Title Description
FG9Y Short term patent issued
MK4Y Short term patent expired